Breast Cancer Diagnostics Market Assessment and Key Insights Analyzed till 2022

 Mark Engine
  16th-Sep-2019
 33
XXF_1568628582_1.jpg FactMR.com

Breast cancer is a cancer that develops when cells and tissues in the breast begin to grow out of control. Usually forming into a tumor, breast cancer is visible as a lump surrounding the internal breast tissues. Breast cancer tumor is malignant, and occurs almost entirely in women, apart from exceptional occurrences in men.

Get Report Sample Copy @ https://www.factmr.com/connectus/sample?flag=S&rep_id=55

Fact.MR, in its latest report, estimates the global breast cancer diagnostics market to register a moderate expansion at 4.7% CAGR during the forecast period 2017 to 2022.

Screening Practices of Breast Cancer Witnessed to Alter Early Detection Practices

Breast cancer has become the most common type of cancer for women across the globe. The number of women suffering from breast cancer is witnessing a surge. This has led towards necessity for efficient early detection of breast cancer. Mammography screening, an established method adopted across several countries, has been recently been observed to offer inconclusive test results. Risk-adapted, personalized therapy and screening are predicted to resolve these difficulties. In addition, tomosynthesis, a new imaging technology, has been seen to overcome the drawbacks of mammography.

Screening options for breast cancer have been witnessing a rise, and have been altering practices of early detection across industrialized economies. Moreover, countries such as Brazil, India and China are focusing on development of cost-effective screening strategies capable of being adapted as per requirements.

Market Taxonomy

Test Type

End User

BRCA

Hospital Associated Labs

ER & PR

Independent Diagnostic Laboratories

CEA

Cancer Research Institutes

KRAS Mutation

Others

HER 2

PSA

CA Test

EGFR Mutation Test

Immunohistochemistry

Others

Inquire More or Share Questions if any @ https://www.factmr.com/report/55/breast-cancer-diagnostics-market

Introduction of Hybrid Imaging Instruments Offering Enhanced Accuracy to Drive Growth of the Market

The global breast cancer diagnostics market has been witnessing a robust transformation on the back of several technological advancements in the diagnostic platforms. The market has witnessed the introduction of hybrid imaging instruments which offer an enhanced accuracy. These advancements have been augmenting growth of the global breast cancer diagnostics market. Increasing incidences of breast cancer and growth in older female population are expected to create lucrative growth opportunities for breast cancer diagnostics. In contrast, shortage of skilled and trained personnel is expected to pose a major challenge to the market growth of breast cancer diagnostics.

By test type, BRCA is expected to remain dominant in the market, with sales poised to surpass US$ 500 Mn by 2022-end. CA test for breast cancer are expected to exhibit the highest CAGR in the market through 2022, followed by ER & PR test. However, revenue from CA, and ER & PR tests will remain low during the forecast period. HER 2 test will remain the second largest test type segment in the global breast cancer diagnostics market. Revenue from EGFR mutation test will continue to be low in the global breast cancer diagnostics market.

Hospital-associated Labs to Remain the Largest End-Users in Breast Cancer Diagnostics Market

Hospital-associated labs are expected to remain the largest end-users of breast cancer diagnostics in the global market. Breast cancer diagnostics in hospital-associated labs will account for the largest revenues by 2022-end, followed by independent diagnostic laboratories. Cancer research institutes are expected to register the highest CAGR through 2022.

Request for Research Methodology @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=55

Competition Tracking

Key market players mentioned in Fact.MR’s report include Abbott Laboratories, Roche Holding AG, Thermo Fischer Scientific, Inc., Siemens AG, Bio-Rad Laboratories, Inc., Illumina, Inc., Biocept, Inc., Epigenomics AG, AstraZeneca plc, Myriad Genetics, Inc., and Quest Diagnostics Incorporated.

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com

Web: https://www.factmr.com/

Domain: Medical
Category:
Contact Person Address: info@factmr.com
Posted By: Mark Engine and Contact Mark Engine
SEMICONDUCTOR ANALYTICS

Recent Press Releases

Trash Rakes Market Forecast, Growth ...

Trash rakes have always been a part of hydroelectric power plants, preventing debris from entering the plant. Over the years, the trash rakes have gained increasing demand in water

18 October, 2019

Induction Sealing Machine Market For...

The induction sealing machines are used for cap sealing and threading of caps—both plastic as well as aluminum—of packaged products offered in the plastic bottles and

18 October, 2019

Acoustic Emission Testing Market Gro...

Acoustic emission testing is used for the analysis and detection of acoustic signals in order to gain valuable information regarding discontinuity in a material and its origin. Aco

18 October, 2019